KALA
Kala Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$45.17M
P/E Ratio
—
EPS
$-102.01
Beta
-2.24
52W High
$1030.00
52W Low
$2.40
50-Day MA
$7.67
200-Day MA
$139.29
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Kala Pharmaceuticals Inc
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of therapies using its proprietary nanoparticle-based mucus penetrating particle (MPP) technology for the treatment of eye diseases. The company is headquartered in Watertown, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $1.33M |
| EBITDA | $-33.23M |
| Operating Margin | 0.00% |
| Return on Equity | -238.70% |
| Return on Assets | -69.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $12.56 |
| Price-to-Book | 4.20 |
| Price-to-Sales (TTM) | 23.75 |
| EV/Revenue | 0.0421 |
| EV/EBITDA | -0.16 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $18.59M |
| Float | $18.59M |
| % Insiders | 1.30% |
| % Institutions | 0.63% |
Historical Volatility
HV 10-Day
116.37%
HV 20-Day
142.78%
HV 30-Day
134.78%
HV 60-Day
138.89%
HV Rank
—
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 5/25/2026